Thyroid hormone therapy for postoperative nonthyroidal illnesses: A systematic review and synthesis

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4526-4534

  Kaptein, Elaine M ^a   Sanchez, Andrea ^a   Beale, Elizabeth ^a   Chan, Linda S ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT; LIOTHYRONINE; PLACEBO; THYROTROPIN; THYROXINE;

CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; DRUG MEGADOSE; HEART ATRIUM FIBRILLATION; HEART INDEX; HEART RATE; HEART SURGERY; HEART VALVE SURGERY; HORMONAL THERAPY; HUMAN; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC VASCULAR RESISTANCE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; ADULT; DOSE RESPONSE; DRUG ADMINISTRATION; HORMONE SUBSTITUTION; META ANALYSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIAL; UTILIZATION REVIEW;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HORMONE REPLACEMENT THERAPY; HUMANS; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIIODOTHYRONINE;

EID: 77957784837     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1052     Document Type: Review

References (37)

1. Acker CG, Flick R, Shapiro R, Scantlebury VP, Jordan ML, Vivas C, Greenberg A, Johnson JP 2002 Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). Am J Transplant 2:57-61
2. Ronald A, Dunning J 2006 Does perioperative thyroxine have a role during adult cardiac surgery? Interact Cardiovasc Thorac Surg 5:166-178
3. Vohra HA, Bapu D, Bahrami T, Gaer JA, Satur CM 2008 Does perioperative administration of thyroid hormones improve outcome following coronary artery bypass grafting? J Card Surg 23:92-96
4. Ranasinghe AM, Bonser RS 2010 Thyroid hormone in cardiac surgery. Vascul Pharmacol 52:131-137
5. Cini G, Carpi A, Mechanick J, Cini L, Camici M, Galetta F, Giardino R, Russo MA, Iervasi G 2009 Thyroid hormones and the cardiovascular system: pathophysiology and interventions. Biomed Pharmacother 63:742-753
6. Spratt DI, Frohnauer M, Cyr-Alves H, Kramer RS, Lucas FL, Morton JR, Cox DF, Becker K, Devlin JT 2007 Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am J Physiol Endocrinol Metab 293:E310-E315
7. Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS 2006 Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Circulation 114:I245-I250
8. Sirlak M, Yazicioglu L, Inan MB, Eryilmaz S, Tasoz R, Aral A, Ozyurda U 2004 Oral thyroid hormone pretreatment in left ventricular dysfunction. Eur J Cardiothorac Surg 26:720-725
9. Mullis-Jansson SL, Argenziano M, Corwin S, Homma S, Weinberg AD, Williams M, Rose EA, Smith CR 1999 A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 117:1128-1134
10. Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K 1995 Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 333:1522-1527
11. Novitzky D, Cooper DK, Barton CI, Greer A, Chaffin J, Grim J, Zuhdi N 1989 Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 98:972-977; discussion 977-978
12. Teiger E, Menasché P, Mansier P, Chevalier B, Lajeunie E, Bloch G, Piwnica A 1993 Triiodothyronine therapy in open-heart surgery: from hope to disappointment. Eur Heart J 14:629-633
13. Güden M, Akpinar B, Sagobap E, Sanisoolu I, Cakali E, Bayindir O 2002 Effects of intravenous triiodothyronine during coronary artery bypass surgery. Asian Cardiovasc Thorac Ann 10:219-222
14. Vavouranakis I, Sanoudos G, Manios A, Kalogeropoulou K, Sitaras K, Kokkinos C 1994 Triiodothyronine administration in coronary artery bypass surgery: effect on hemodynamics. J Cardiovasc Surg (Torino) 35:383-389
15. Bennett-Guerrero E, Jimenez JL, White WD, D'Amico EB, Baldwin BI, Schwinn DA 1996 Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. JAMA 275:687-692
16. Klemperer JD, Klein IL, Ojamaa K, Helm RE, Gomez M, Isom OW, Krieger KH 1996 Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg 61:1323-1327; discussion 1328-1329
17. Choi YS, Kwak YL, Kim JC, Chun DH, Hong SW, Shim JK 2009 Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery. Anaesthesia 64:871-877
18. Magalhães AP, Gus M, Silva LB, Schaan BD 2006 Oral triiodothyronine for the prevention of thyroid hormone reduction in adult valvular cardiac surgery. Braz J Med Biol Res 39:969-978
19. Kaptein EM, Beale E, Chan LS 2009 Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. J Clin Endocrinol Metab 94:3663-3675
20. Novitzky D, Cooper DK, Swanepoel A 1989 Inotropic effect of triiodothyronine (T3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 3:140-145
21. Novitzky D, Fontanet H, Snyder M, Coblio N, Smith D, Parsonnet V 1996 Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery. Cardiology 87:509-515
22. Carrel T, Eckstein F, Englberger L, Mury R, Mohacsi P 2002 Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature. Eur J Heart Fail 4:577-582
23. Ott RA, Gutfinger DE, Alimadadian H, Miller M, Selvan A, Weinberg D, Hlapcich WL, Tanner TM 1999 Reduced postoperative atrial fibrillation using multidrug prophylaxis. J Card Surg 14:437-443
24. Malik FS, Mehra MR, Uber PA, Park MH, Scott RL, Van Meter CH 1999 Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail 5:31-37
25. Hamilton MA, Stevenson LW, Fonarow GC, Steimle A, Goldhaber JI, Child JS, Chopra IJ, Moriguchi JD, Hage A 1998 Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol 81:443-447
26. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, Guyatt GH, Harbour RT, Haugh MC, Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N, Mason J, Middleton P, Mrukowicz J, O'Connell D, Oxman AD, Phillips B, Schünemann HJ, Edejer TT, Varonen H, Vist GE, Williams Jr JW, Zaza S 2004 Grading quality of evidence and strength of recommendations. BMJ 328:1490-1494
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG 2003 Measuring inconsistency in meta-analyses. BMJ 327:557-560
28. Egger M, Davey Smith G, Schneider M, Minder C 1997 Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
29. Kaptein EM, Hays MT, Ferguson DC 1994 Thyroid hormone metabolism. A comparative evaluation. Vet Clin North Am Small Anim Pract 24:431-466
30. Higgins JPT, Green S, eds. 2009 Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration Version 5.0.2. Hoboken, NJ: Wiley-Blackwell
31. Cohen J 1977 Statistical power analysis for the behavioral sciences, revised ed. New York: Academic Press; 183-184
32. Motulsky H 1995 Intuitive biostatistics. New York: Oxford University Press; 285-286
33. Davis PJ, Davis FB 2002 Nongenomic actions of thyroid hormone on the heart. Thyroid 12:459-466
34. Schmidt BM, Martin N, Georgens AC, Tillmann HC, Feuring M, Christ M, Wehling M 2002 Nongenomic cardiovascular effects of triiodothyronine in euthyroid male volunteers. J Clin Endocrinol Metab 87:1681-1686
35. Faber J, Wiinberg N, Schifter S, Mehlsen J 2001 Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 145:391-396
36. Biondi B, Palmieri EA, Lombardi G, Fazio S 2002 Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. J Clin Endocrinol Metab 87:968-974
37. Dimmick S, Badawi N, Randell T 2004 Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev 3:CD004220